Myriad Genetics Inc. (MYGN)
NASDAQ: MYGN
· Real-Time Price · USD
5.71
-0.18 (-3.06%)
At close: Aug 15, 2025, 3:59 PM
5.75
0.61%
After-hours: Aug 15, 2025, 07:15 PM EDT
Myriad Genetics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -330.5M | -100K | -42.5M | -22.1M | -36.7M | -26M | -31.2M | -61.3M | -116.1M | -54.7M | -42.3M | -35.1M | -14.1M | -20.5M | -7.6M | 24.6M | -4.7M | -39.5M |
Depreciation & Amortization | 14.1M | 14.4M | 14.8M | 15.6M | 15.1M | 15.7M | 15.1M | 14.1M | 13.3M | 19.4M | 13.7M | 13.1M | 12.9M | 13M | 13.3M | 14.2M | 16.9M | 18.4M |
Stock-Based Compensation | 10.7M | 9.5M | 10.9M | 12.4M | 14.5M | 12M | 10.4M | 11.6M | 11.2M | 7.5M | 8.2M | 9.4M | 10.4M | 10.1M | 8.4M | 10M | 8.9M | 9M |
Other Working Capital | -14.1M | -12M | -25.8M | 4.5M | -1.9M | -21M | -56.1M | 8.3M | 89.2M | -12.7M | 3.1M | -1.5M | -43.3M | -43.5M | -37.1M | 66.3M | -2.3M | 93.2M |
Other Non-Cash Items | 319.3M | 3.3M | 46.1M | 3.2M | 13.9M | -900K | -6M | 20.5M | -8M | 16.9M | 18M | 13.5M | 2.8M | 14M | 1.5M | -126M | -21M | 4.6M |
Deferred Income Tax | -200K | -31.3M | 1.5M | -1.1M | -1.9M | 1.2M | -1.7M | -500K | -400K | 2M | -10M | -11.1M | -5.1M | -5.7M | -8.4M | -15.2M | 400K | -11.5M |
Change in Working Capital | -27M | -12.1M | -24.2M | -7.3M | -2.3M | -20.6M | -41.3M | -6.5M | 99.1M | -24.3M | 4.7M | 7.4M | -56.6M | -57.4M | -17.1M | 53.1M | -4.9M | 90.8M |
Operating Cash Flow | -13.6M | -16.3M | 6.6M | 700K | 2.6M | -18.6M | -54.7M | -22.1M | -900K | -33.2M | -7.7M | -2.8M | -49.7M | -46.5M | -9.9M | -39.3M | -4.4M | 71.8M |
Capital Expenditures | -6.9M | -8.3M | -5.9M | -6.3M | -8.9M | -8.6M | -13.5M | -17.5M | -18.8M | -23.5M | -14.6M | -17.7M | -6.7M | -6.3M | -3.4M | -3M | -4.5M | -7.1M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 379.1M | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.4M | -13.3M | -33.4M | -52.1M | -46.8M | -64.4M | -36.6M | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | 5M | 2.5M | 1.5M | 1.5M | 15M | 30.6M | 58.1M | 40.6M | 42.4M | 28.1M | 17.1M | 24.3M | 11.8M | 9.7M | 15.3M |
Other Investing Acitivies | n/a | n/a | n/a | 8.8M | n/a | n/a | n/a | n/a | n/a | n/a | -57.2M | n/a | n/a | n/a | n/a | -32.5M | 32.5M | n/a |
Investing Cash Flow | -6.9M | -8.3M | -5.9M | 7.5M | -6.4M | -7.1M | -12M | -2.5M | 11.8M | 34.6M | -35.6M | 11.4M | -12M | -41.3M | -25.9M | 291M | 1.1M | 8.2M |
Debt Repayment | -100K | 19.4M | 400K | -100K | -100K | -100K | -100K | -100K | 40M | n/a | n/a | n/a | n/a | n/a | n/a | -106.4M | -50M | -70M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -5.8M | 1.7M | -3M | 2.5M | -8.7M | 122M | -2.4M | -1.6M | -4.9M | -2.1M | -3.6M | 2.5M | -4.8M | -1.1M | 31.9M | 23.5M | 21.5M |
Financial Cash Flow | 2.6M | 13.6M | 2.1M | -3.1M | 2.4M | -8.8M | 121.9M | -2.5M | 38.4M | -4.9M | -2.1M | -3.6M | 2.5M | -4.8M | -1.1M | -74.5M | -26.5M | -48.5M |
Net Cash Flow | -17.3M | -10.9M | 2.1M | 8.6M | -4.4M | -35.3M | 55.9M | -27.7M | 49.6M | -3.3M | -44.3M | 4.5M | -59.4M | -93.2M | -36.8M | 176.8M | -30.5M | 31.9M |
Free Cash Flow | -20.5M | -24.6M | 700K | -5.6M | -6.3M | -27.2M | -68.2M | -39.6M | -19.7M | -56.7M | -22.3M | -20.5M | -56.4M | -52.8M | -13.3M | -42.3M | -8.9M | 64.7M |